PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ as follows: Date:Tuesday, May 20, 2025 Time:1:30pm ET Webcast:Click Here To schedule a 1x1 meeting with management, please contact meetings@hcwco.com. The live and archived webcast will be accessible fr ...

SAN JOSE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- In its 2024 Sustainability Report and Analyst Download published today, California Water Service Group (Group) (NYSE: CWT) highlights recent and ongoing emissions reductions, water quality and infrastructure investments, employee development opportunities, corporate responsibility efforts, and more. The 2024 Sustainability Report showcases progress made in Group’s four key focus areas, including:Protecting the planet Reducing Scope 1 and 2 greenhouse gas em ...

VANCOUVER, British Columbia, May 12, 2025 (GLOBE NEWSWIRE) -- Finning International Inc. (TSX: FTT) (“Finning”, the “Company”, “we”, “our” or “us”) reported first quarter 2025 results today. All monetary amounts are in Canadian dollars unless otherwise stated. HIGHLIGHTSAll comparisons are to Q1 2024 results unless indicated otherwise. Q1 2025 revenue of $2.8 billion and net revenue (2) of $2.5 billion were up 9% and 7%, respectively, driven by a 7% increase in new equipment revenue and an 11% increase in p ...

Investor Call to be held at 11:00 AM Eastern TimeBOHEMIA, N.Y., May 12, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it will file a Form 10Q and issue a press release after the close on May 13, 2025, for its first quarter financial results ended March 31, 2025. The Company will conduct a conference call for all interested parties on Wednesday, May 14th, at 11:00 a.m. Eastern Time t ...

Douglas Dynamics (PLOW) Sarah Lauber, EVP and CFO, rings the opening bell on the New York Stock Exchange on May 12, 2025 MILWAUKEE, May 12, 2025 (GLOBE NEWSWIRE) -- Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of commercial work truck attachments and equipment, today celebrated its 15th anniversary as a publicly traded company on the New York Stock Exchange (NYSE). To mark the milestone, Sarah Lauber, Executive Vice President and Chief Financial Officer, rang th ...

CALGARY, Alberta and TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Magnetic North Acquisition Corp. (TSXV: MNC; MNC.PR.A) (“Magnetic North” or the “Company”) announces that its principal regulator, the Alberta Securities Commission (the “ASC”), has accepted the Company’s request for, and the ASC has granted, a management cease trade order (the “MCTO”). As previously announced on May 8, 2025, the application for the MCTO was made by the Company due to a delay in the preparation and filing of the Company’s annual ...

CALGARY, Alberta, May 12, 2025 (GLOBE NEWSWIRE) -- TSX-V: CWV: Crown Point Energy Inc. (“Crown Point”, the “Company” or “we”) today announced its financial and operating results for the three months ended March 31, 2025. Selected information is outlined below and should be read in conjunction with the Company’s March 31, 2025 unaudited condensed interim consolidated financial statements and management’s discussion and analysis (“MD&A”) that are being filed with Canadian securities regulatory authorities and ...

Core Viewpoint - Apimeds Pharmaceuticals US, Inc. has successfully completed its initial public offering, raising $13.5 million to fund clinical trials and other operational needs [1][3]. Group 1: Initial Public Offering Details - The company closed its initial public offering of 3,375,000 shares at a price of $4.00 per share, with trading commencing on May 9, 2025 [1]. - Gross proceeds from the offering amounted to $13.5 million before expenses [1]. - Underwriters were granted a 45-day option to purchase an additional 506,250 shares at the public offering price [1]. Group 2: Use of Proceeds - The net proceeds from the offering are intended to fund a Phase III clinical trial for knee osteoarthritis [3]. - The company plans to initiate at least one non-registered corporate sponsorship study in multiple sclerosis [3]. - Proceeds will also be allocated for manufacturing its product candidate and general working capital needs [3]. Group 3: Company Overview - Apimeds is a clinical stage biopharmaceutical company developing Apitox, a bee venom-based toxin with potential therapeutic effects [6]. - The product is being developed as a treatment for knee pain in osteoarthritis patients who do not respond adequately to conventional therapies [6].

Company Overview - Perimeter Acquisition Corp. I is a special purpose acquisition company targeting companies in the defense and national security sectors, leveraging its management's extensive investment and operational experience [5] - The company also aims to explore opportunities at the intersection of defense, technology, and national security, believing its management team can drive value creation post-business combination [5] Initial Public Offering (IPO) Details - The company announced the pricing of its upsized initial public offering of 21,000,000 units at $10.00 per unit, with units expected to trade on Nasdaq under the ticker symbol "PMTRU" starting May 13, 2025 [1] - The offering is anticipated to close on May 14, 2025, subject to customary closing conditions, with Citigroup Global Markets Inc. serving as the sole book-running manager [2] - An additional 3,150,000 units may be purchased by the underwriter to cover over-allotments [2] Regulatory and Compliance Information - A registration statement on Form S-1 related to these securities has been filed with the SEC and was declared effective on May 12, 2025, with the offering being made only by means of a prospectus [3]

Company Simultaneously Announces Transformative Transaction to Privatize Certain Fresh Produce Segment Assets and Focus Resources on Global Cannabis Growth Opportunities Canadian Cannabis Delivers Strongest EBITDA Performance in 3 Years; Maintains Top 3 Market Share Nationally Despite Reduction in Lower-Margin Branded SalesCanadian Cannabis Net Income and Adjusted EBITDA Increased 258% and 64% Year-over-YearInternational Medical Export Cannabis Sales Increased 285% Year-Over-YearCommenced Cannabis Sales in ...